ProKidney
PROK
55 hedge funds and large institutions have $44.1M invested in ProKidney in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 13 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
10% less funds holding
Funds holding: 61 → 55 (-6)
20.42% less ownership
Funds ownership: 60.44% → 40.01% (-20%)
39% less capital invested
Capital invested by funds: $72.2M → $44.1M (-$28.1M)
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
50% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 24
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $10K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$355K |
| 2 |
HF
HRT Financial
New York
|
+$252K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.7K |
| 4 |
Jane Street
New York
|
+$42.4K |
| 5 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
|
+$28.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$17.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.6M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$318K |
| 4 |
Squarepoint
New York
|
-$250K |
| 5 |
BlackRock
New York
|
-$205K |
PROK Hedge Fund Activity: Q1 2024 in Review
55 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q1 2024, worth a combined $44.1M — down 39% from $72.2M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of PROK and 7 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 12 added.
The largest buyer was Fidelity Investments, adding an estimated $355K. The largest seller was Morgan Stanley, cutting an estimated $17.7M.
- 55 institutional investors held ProKidney (PROK) as of Q1 2024, down from 61 in Q4 2023.
- Funds reported $44.1M of ProKidney stock for Q1 2024, down 39% quarter-over-quarter.
- 7 funds opened new ProKidney positions in Q1 2024 and 13 closed out, a net change of -6 holders.
- The largest ProKidney buyer in Q1 2024 was Fidelity Investments, an estimated $355K added.
- The largest ProKidney seller in Q1 2024 was Morgan Stanley, an estimated $17.7M sold.
Based on aggregated 13F filings for Q1 2024.